rasagiline has been researched along with Brain Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaugrund, E; Cohen, S; Fine, T; Litinetsky, L; Mayk, A; Nyska, A; Speiser, Z | 1 |
| Cohen, S; Eliash, S; Mayk, A; Speiser, Z | 1 |
2 other study(ies) available for rasagiline and Brain Ischemia
| Article | Year |
|---|---|
Rasagiline is neuroprotective in an experimental model of brain ischemia in the rat.
Topics: Animals; Brain Infarction; Brain Ischemia; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Indans; Infarction, Middle Cerebral Artery; Male; Maze Learning; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Wistar; Recovery of Function; Time Factors; Treatment Outcome | 2007 |
Studies with rasagiline, a MAO-B inhibitor, in experimental focal ischemia in the rat.
Topics: Animals; Blood Pressure; Brain Ischemia; Drug Evaluation, Preclinical; Indans; Infarction, Middle Cerebral Artery; Male; Monoamine Oxidase Inhibitors; Motor Activity; Rats; Rats, Wistar | 1999 |